Publications by authors named "Brian D Jamieson"

Claim this Profile
A
Avatrombopag for treating children and adolescents with immune thrombocytopenia: a plain language summary.
Rachael F Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John D Grainger, Brian D Jamieson

Expert Rev Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.
Hiroki Yamaguchi, Masaki Iino, Shugo Kowata, Ryusuke Yamamoto, Jun Yamanouchi, Brian D Jamieson

Int J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.
Hiroki Yamaguchi, Masaki Iino, Shugo Kowata, Ryusuke Yamamoto, Jun Yamanouchi, Brian D Jamieson

Int J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study.
Rachael F Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John D Grainger, Brian D Jamieson

Lancet Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy, and treatment satisfaction in adults with ITP who switched to avatrombopag from another TPO-RA.
Michael D Tarantino, Kailash Mosalpuria, Scott Kolodny, Jessica Zhang, Michael Vredenburg, Brian D Jamieson

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure.
Sanjaya K Satapathy, Vinay Sundaram, Mitchell L Shiffman, Brian D Jamieson

Medicine (Baltimore)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma gastric biomarker evaluation with avatrombopag dosing in patients with chronic immune thrombocytopenia in phase 3 trials.
James B Bussel, Michael D Tarantino, Eun-Ju Lee, Brian D Jamieson

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomized, double-blind, active-controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP.
Michael D Tarantino, James B Bussel, Eun-Ju Lee, Brian D Jamieson

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avatrombopag ethnic sensitivity analysis in chronic liver disease and thrombocytopenia patients: individual-level pooled analysis.
Jun Lu, Brian D Jamieson, Ai-Min Hui

Therap Adv Gastroenterol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial.
Hanny Al-Samkari, Jaroslaw Kolb-Sielecki, Sufiia Z Safina, Xiaoqiang Xue, Brian D Jamieson

Lancet Haematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia.
Wojciech Jurczak, Krzysztof Chojnowski, Jiří Mayer, Katarzyna Krawczyk, Brian D Jamieson

Br J Haematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism, Excretion, and Mass Balance of Solithromycin in Humans.
Christopher MacLauchlin, Stephen E Schneider, Kara Keedy, Prabhavathi Fernandes, Brian D Jamieson

Antimicrob Agents Chemother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid.
Sara N Salerno, Andrea Edginton, Michael Cohen-Wolkowiez, Christoph P Hornik, Kevin M Watt, Brian D Jamieson

CPT Pharmacometrics Syst Pharmacol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects.
Borje Darpo, Philip T Sager, Prabhavathi Fernandes, Brian D Jamieson, Kara Keedy

J Antimicrob Chemother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
Thomas M File, Barbara Rewerska, Violeta Vucinic-Mihailovic, Joven Roque V Gonong, Anita F Das, Brian D Jamieson

Clin Infect Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea.
Edward W Hook, Matthew Golden, Brian D Jamieson, Paula B Dixon, Hanne S Harbison

Clin Infect Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment.
Brian D Jamieson, Sabrina Ciric, Prabhavathi Fernandes

Antimicrob Agents Chemother· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia.
David Oldach, Kay Clark, Jennifer Schranz, Anita Das, J Carl Craft, Brian D Jamieson

Antimicrob Agents Chemother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracic and lumbar paravertebral blocks for outpatient lithotripsy.
Brian D Jamieson, Edward R Mariano

J Clin Anesth· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis